196 related articles for article (PubMed ID: 22507532)
21. Location of disease in patients who die from endometrial cancer: a study of 414 patients from a single institution.
Barlin JN; Wysham WZ; Ferda AM; Khoury-Collado F; Cassella DK; Alektiar KM; Hensley ML; Chi DS; Barakat RR; Abu-Rustum NR
Int J Gynecol Cancer; 2012 Nov; 22(9):1527-31. PubMed ID: 23051960
[TBL] [Abstract][Full Text] [Related]
22. Patient compliance for postoperative radiotherapy and survival outcome of women with stage I endometrioid endometrial cancer.
Matsuo K; Machida H; Ragab OM; Garcia-Sayre J; Yessaian AA; Roman LD
J Surg Oncol; 2017 Sep; 116(4):482-491. PubMed ID: 28543055
[TBL] [Abstract][Full Text] [Related]
23. Association of Neoadjuvant Chemotherapy With Overall Survival in Women With Metastatic Endometrial Cancer.
Tobias CJ; Chen L; Melamed A; St Clair C; Khoury-Collado F; Tergas AI; Hou JY; Hur C; Ananth CV; Neugut AI; Hershman DL; Wright JD
JAMA Netw Open; 2020 Dec; 3(12):e2028612. PubMed ID: 33295973
[TBL] [Abstract][Full Text] [Related]
24. Risk of cardiovascular disease among women with endometrial cancer compared to cancer-free women in the Women's Health Initiative.
Felix AS; Lehman A; Foraker RE; Naughton MJ; Bower JK; Kuller L; Sarto GE; Stefanick ML; Van Horn L; Jackson RD; Paskett ED
Cancer Epidemiol; 2017 Dec; 51():62-67. PubMed ID: 29049937
[TBL] [Abstract][Full Text] [Related]
25. Cardiovascular disease diagnoses among older women with endometrial cancer.
Anderson C; Olshan AF; Bae-Jump VL; Brewster WR; Lund JL; Nichols HB
Gynecol Oncol; 2022 Oct; 167(1):51-57. PubMed ID: 36008183
[TBL] [Abstract][Full Text] [Related]
26. Impact of Conservative Managements in Young Women With Grade 2 or 3 Endometrial Adenocarcinoma Confined to the Endometrium.
Gonthier C; Trefoux-Bourdet A; Koskas M
Int J Gynecol Cancer; 2017 Mar; 27(3):493-499. PubMed ID: 28187090
[TBL] [Abstract][Full Text] [Related]
27. The incidence of endometrial cancer after endometrial ablation in a low-risk population.
Neuwirth RS; Loffer FD; Trenhaile T; Levin B
J Am Assoc Gynecol Laparosc; 2004 Nov; 11(4):492-4. PubMed ID: 15701191
[TBL] [Abstract][Full Text] [Related]
28. Secondary cancer prevention during follow-up for endometrial cancer.
Kwon JS; Elit L; Saskin R; Hodgson D; Grunfeld E
Obstet Gynecol; 2009 Apr; 113(4):790-795. PubMed ID: 19305321
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis.
Rossi PJ; Jani AB; Horowitz IR; Johnstone PA
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):134-8. PubMed ID: 17855014
[TBL] [Abstract][Full Text] [Related]
30. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
[TBL] [Abstract][Full Text] [Related]
31. The association between histological subtype of a first primary endometrial cancer and second cancer risk.
Rhoades J; Vetter MH; Fisher JL; Cohn DE; Salani R; Felix AS
Int J Gynecol Cancer; 2019 Feb; 29(2):290-298. PubMed ID: 30718311
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors for rural endometrial cancer patients in a population-based cohort.
Blackburn BE; Soisson S; Rowe K; Snyder J; Fraser A; Deshmukh V; Newman M; Smith K; Herget K; Kirchhoff AC; Kepka D; Werner TL; Gaffney D; Mooney K; Hashibe M
BMC Public Health; 2019 Jul; 19(1):921. PubMed ID: 31291920
[TBL] [Abstract][Full Text] [Related]
33. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
Cosgrove CM; Cohn DE; Rhoades J; Felix AS
Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
[TBL] [Abstract][Full Text] [Related]
34. Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use.
Cuenca RE; Giachino J; Arredondo MA; Hempling R; Edge SB
Cancer; 1996 May; 77(10):2058-63. PubMed ID: 8640670
[TBL] [Abstract][Full Text] [Related]
35. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
Petitti DB; Porterfield D
Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
[TBL] [Abstract][Full Text] [Related]
36. Pre-diagnosis health-related quality of life and survival in older women with endometrial cancer.
Klapheke AK; Keegan THM; Ruskin R; Cress RD
Support Care Cancer; 2020 Oct; 28(10):4901-4909. PubMed ID: 32008090
[TBL] [Abstract][Full Text] [Related]
37. Surgical staging for endometrial cancer in the elderly - is there a role for lymphadenectomy?
Lowery WJ; Gehrig PA; Ko E; Secord AA; Chino J; Havrilesky LJ
Gynecol Oncol; 2012 Jul; 126(1):12-5. PubMed ID: 22588178
[TBL] [Abstract][Full Text] [Related]
38. Metformin and the risk of endometrial cancer: a population-based cohort study.
Ko EM; Stürmer T; Hong JL; Castillo WC; Bae-Jump V; Funk MJ
Gynecol Oncol; 2015 Feb; 136(2):341-7. PubMed ID: 25499603
[TBL] [Abstract][Full Text] [Related]
39. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship.
Fader AN; Arriba LN; Frasure HE; von Gruenigen VE
Gynecol Oncol; 2009 Jul; 114(1):121-7. PubMed ID: 19406460
[TBL] [Abstract][Full Text] [Related]
40. Obesity-related endometrial cancer: an update on survivorship approaches to reducing cardiovascular death.
Laskey RA; McCarroll ML; von Gruenigen VE
BJOG; 2016 Jan; 123(2):293-8. PubMed ID: 26841334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]